B
Solon Current
Buckeye CurrentSolon: Cleveland suburb, corporate and family blend

Advertisement · Why this ad?

Business

Antengene Presents Latest Preclinical Results of ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at ACR 2026

Tara Kim
Reporter · Thursday, November 12, 2026 at 3:11 AM · 1 min read
Antengene Presents Latest Preclinical Results of ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at ACR 2026 — Solon Business news

SHANGHAI and HONG KONG, Nov. 11, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune diseases, solid tumors and hematological…

Up nextVeteran says skills used as police officer, learned in militaryBusiness · 1 min read
You're offline — showing the last loaded page